Table 3.
Microbiological isolations on bronchoalveolar lavage
| N | % | |
|---|---|---|
| Patients | 131 | |
| Viruses | 57 | |
| SARS-CoV-2 | 43 | 75.44 |
| HHV-6 | 4 | 7.02 |
| HSV-1 | 2 | 3.51 |
| CMV | 4 | 7.02 |
| EBV | 2 | 3.51 |
| RSV | 1 | 1.75 |
| Metapneumovirus | 1 | 1.75 |
| Bacteria | 30 | |
| Staphylococcus aureus | 9 | 30 |
| Escherichia coli | 5 | 16.68 |
| Klebsiella pneumoniae | 4 | 13.33 |
| Pseudomonas aeruginosa | 4 | 13.33 |
| Chlamydia pneumoniae | 1 | 3.33 |
| Mycoplasma pneumoniae | 1 | 3.33 |
| Others | 6 | 20 |
| Fungi | 17 | |
| Candida albicans | 11 | 64.70 |
| Aspergillus spp. | 4 | 23.54 |
| Others | 2 | 11.77 |
CMV, Cytomegalovirus; EBV, Epstein-Barr virus; HHV-6, Human herpesvirus 6; HSV-1, herpes simplex virus 1; RSV, respiratory syncytial virus; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2.